Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab with Gemcitabine and Albumin-paclitaxel in Pancreatic Cancer
NCT05346146Phase 2Unknown
- Sponsor
- Renji Hospital
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in pancreatic cancer (PC), sponsored by Renji Hospital. Status: unknown.
02
Drugs
sintilimab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT05346146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05346146.